Fresenius Medical Care Ag ADR
(FMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 143,678 | 942,261 | 705,788 | 444,635 | 237,689 |
| Depreciation Amortization | 469,950 | 1,936,899 | 1,353,365 | 895,745 | 470,154 |
| Income taxes - deferred | -24,015 | -43,694 | -60,513 | -67,194 | -10,431 |
| Accounts receivable | -383,041 | -49,184 | -43,231 | -24,356 | -321,006 |
| Accounts payable and accrued liabilities | -27,075 | -9,194 | -52,646 | -30,055 | -181,446 |
| Other Working Capital | -362,459 | -134,931 | -185,499 | -276,322 | -457,520 |
| Other Operating Activity | 336,282 | -358,606 | -138,256 | 26,087 | 440,651 |
| Operating Cash Flow | $153,319 | $2,283,551 | $1,579,008 | $968,539 | $178,090 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -150,805 | -724,648 | -489,297 | -350,274 | -179,388 |
| Net Acquisitions | 8,665 | 1,083 | 16,677 | -22,289 | -24,987 |
| Purchase Of Investment | -49,254 | -111,303 | -92,794 | -91,316 | -47,879 |
| Sale Of Investment | 16,133 | 60,762 | 51,964 | 28,633 | 15,115 |
| Investing Cash Flow | $-175,262 | $-774,106 | $-513,450 | $-435,245 | $-237,139 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 111,151 | 755,530 | 665,502 | 683,295 | 202,290 |
| Debt Issued | 6,947 | 1,039,821 | 1,034,077 | 264,286 | 261,879 |
| Debt Repayment | -15,235 | -784,532 | -766,978 | -762,347 | -718,307 |
| Common Stock Issued | N/A | 21,233 | 20,296 | 21,438 | 889 |
| Dividend Paid | -89,596 | -740,652 | -618,042 | -568,884 | N/A |
| Other Financing Activity | -11,105 | -1,995,452 | -1,843,082 | -696,573 | -45,975 |
| Financing Cash Flow | $2,162 | $-1,704,051 | $-1,508,226 | $-1,058,785 | $-299,225 |
| Exchange Rate Effect | -33,779 | -24,404 | 71,915 | 39,170 | 12,285 |
| Beginning Cash Position | 1,367,283 | 1,561,072 | 1,492,323 | 1,576,777 | 1,662,713 |
| End Cash Position | 1,313,724 | 1,342,062 | 1,121,570 | 1,090,456 | 1,316,724 |
| Net Cash Flow | $-53,559 | $-219,010 | $-370,753 | $-486,321 | $-345,989 |
| Free Cash Flow | |||||
| Operating Cash Flow | 153,319 | 2,283,551 | 1,579,008 | 968,539 | 178,090 |
| Capital Expenditure | -152,563 | -762,794 | -498,165 | -355,727 | -181,893 |
| Free Cash Flow | 756 | 1,520,757 | 1,080,843 | 612,812 | -3,803 |